160 related articles for article (PubMed ID: 6249835)
21. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease.
Elias AN; Gwinup G; Valenta LJ
Clin Endocrinol (Oxf); 1981 Aug; 15(2):151-4. PubMed ID: 6273025
[TBL] [Abstract][Full Text] [Related]
22. Gel chromatographic characterization of immunoreactive adrenocorticotropin in patients with ACTH hypersecretion.
Reincke M; Allolio B; Deuss U; Winkelmann W
Klin Wochenschr; 1989 Nov; 67(21):1096-100. PubMed ID: 2555628
[TBL] [Abstract][Full Text] [Related]
23. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
Loli P; Berselli ME; Frascatani F; Muratori F; Tagliaferri M
J Endocrinol Invest; 1984 Apr; 7(2):93-6. PubMed ID: 6327800
[TBL] [Abstract][Full Text] [Related]
24. Pituitary Cushing's syndrome and Nelson's syndrome: diagnostic criteria, surgical therapy, and results.
Guthrie FW; Ciric I; Hayashida S; Kerr WD; Murphy ED
Surg Neurol; 1981 Nov; 16(5):316-23. PubMed ID: 6278664
[TBL] [Abstract][Full Text] [Related]
25. Nelson's syndrome: incidence and prognosis.
Kasperlik-Załuska AA; Nielubowicz J; Wisławski J; Hartwig W; Załuska J; Jeske W; Migdalska B
Clin Endocrinol (Oxf); 1983 Dec; 19(6):693-8. PubMed ID: 6317234
[TBL] [Abstract][Full Text] [Related]
26. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.
Lamberts SW; Uitterlinden P; Klijn JM
Acta Endocrinol (Copenh); 1989 Jun; 120(6):760-6. PubMed ID: 2543178
[TBL] [Abstract][Full Text] [Related]
27. Bromocriptine in Nelson's syndrome and Cushing's disease.
Lamberts SW; Birkenhäger JC
Lancet; 1976 Oct; 2(7989):811. PubMed ID: 61490
[No Abstract] [Full Text] [Related]
28. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
29. Dissociation and association between calcitonin and adrenocorticotropin secretion.
Lamberts SW; Hackeng WH; Visser TJ
J Clin Endocrinol Metab; 1980 Mar; 50(3):565-8. PubMed ID: 6244325
[No Abstract] [Full Text] [Related]
30. Vasoactive intestinal polypeptide enhances ACTH levels in some patients with adrenocorticotropin-secreting pituitary adenomas.
Ambrosi B; Bochicchio D; Sartorio A; Morabito F; Faglia G
Acta Endocrinol (Copenh); 1987 Oct; 116(2):216-20. PubMed ID: 2821720
[TBL] [Abstract][Full Text] [Related]
31. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
[TBL] [Abstract][Full Text] [Related]
32. Effects of somatostatin and bromocryptine on the plasma ACTH level in bilaterally adrenalectomized patients with Cushing's disease.
Julesz J; Laczi F; Janáky T; László F
Endokrinologie; 1980 Jul; 76(1):68-72. PubMed ID: 6108208
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.
Mercado-Asis LB; Yanovski JA; Tracer HL; Chik CL; Cutler GB
J Clin Endocrinol Metab; 1997 Feb; 82(2):514-7. PubMed ID: 9024246
[TBL] [Abstract][Full Text] [Related]
34. Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease.
Kemink L; Pieters G; Hermus A; Smals A; Kloppenborg P
J Clin Endocrinol Metab; 1994 Sep; 79(3):887-9. PubMed ID: 8077377
[TBL] [Abstract][Full Text] [Related]
35. Nelson's syndrome after Cushing's disease in childhood: a continuing problem.
Thomas CG; Smith AT; Benson M; Griffith J
Surgery; 1984 Dec; 96(6):1067-77. PubMed ID: 6505960
[TBL] [Abstract][Full Text] [Related]
36. Effect of an oral serotonin antagonist, ketanserin, on plasma ACTH concentrations in Nelson's syndrome.
Prescott RW; Ratcliffe WA; Taylor PK
Br Med J (Clin Res Ed); 1984 Sep; 289(6448):787-8. PubMed ID: 6089950
[TBL] [Abstract][Full Text] [Related]
37. A case of Cushing's disease successfully treated with bromocriptine.
Sumiya N; Hiramatsu K; Arimori S
Jpn J Med; 1990; 29(2):185-90. PubMed ID: 2172607
[TBL] [Abstract][Full Text] [Related]
38. Absence of detectable immunoreactive alpha melanocyte stimulating hormone in plasma in various types of Cushing's disease.
Croughs RJ; Thijssen JH; Mol JA
J Endocrinol Invest; 1991 Mar; 14(3):197-200. PubMed ID: 1649212
[TBL] [Abstract][Full Text] [Related]
39. Nelson's syndrome: case report and review of the literature.
Ullrich I; Lizarralde G
South Med J; 1977 Dec; 70(12):1444-6. PubMed ID: 202034
[TBL] [Abstract][Full Text] [Related]
40. Plasma beta-endorphin responses to somatostatin, thyrotropin-releasing hormone, or vasopressin in Nelson's syndrome.
Oki S; Nakai Y; Nakao K; Imura H
J Clin Endocrinol Metab; 1980 Jan; 50(1):194-7. PubMed ID: 6243130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
